Fresh Take on How to Conduct Rare Disease Clinical Trials
Uncommon Cures, a U.S. company, launched a boutique clinical trial program for rare diseases, underestimating the demand. With eight contracts and talks with over 50 clients, CEO Marshall Summar highlights the need for a new model blending regulatory tasks with a concierge-based facility. The model, expanding internationally with sites in D.C., Utah, Chile, Switzerland, and UAE, aims to streamline trials, reduce costs by over 40%, and improve patient access globally.
Highlighted Terms
Related News
Uncommon Cures, a U.S. company, launched a boutique clinical trial program for rare diseases, underestimating the demand. With eight contracts and talks with over 50 clients, CEO Marshall Summar highlights the need for a new model blending regulatory tasks with a concierge-based facility. The model, expanding internationally with sites in D.C., Utah, Chile, Switzerland, and UAE, aims to streamline trials, reduce costs by over 40%, and improve patient access globally.